Virios Logo Blue.jpg
Virios Therapeutics to Report Third Quarter 2023 Financial Results on Monday, November 13, 2023
06 nov. 2023 07h05 HE | Virios Therapeutics
ATLANTA, Nov. 06, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel, combination antiviral...
Virios Logo Blue.jpg
Virios Therapeutics Announces Termination of At-The-Market Sales Agreement
18 sept. 2023 07h05 HE | Virios Therapeutics
ATLANTA, Sept. 18, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to...
Virios Logo Blue.jpg
Virios Therapeutics CEO Greg Duncan to Present at the SHARE™️ Series Investor Event on Monday, September 18, 2023
12 sept. 2023 07h05 HE | Virios Therapeutics
ATLANTA, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Virios Therapeutics, Inc. (Nasdaq: VIRI) (the “Company”), a development-stage biotechnology company focused on advancing novel antiviral therapies to...
novexploringblocktv
FMW Media Works Corp. Announces its “Exploring The Block” TV Show with Two New Featured Clients, Shivom (OMX) and PascalCoin (PASC)
09 nov. 2018 16h45 HE | NEW TO THE STREET
NEW YORK, Nov. 09, 2018 (GLOBE NEWSWIRE) -- FMW Media Works Corp. announces two new featured clients, Shivom and PascalCoin, both appearing on “Exploring The Block” TV. On November 28, 2018,...